HEMOLUNG RAS
Report
- Report Number
- 3009763347-2023-00018
- Event Type
- Injury
- Date Received
- January 16, 2023
- Date of Event
- December 6, 2017
- Report Date
- January 16, 2023
- Manufacturer
- ALUNG TECHNOLOGIES, INC
- Product Code
- DQR
- PMA / PMN Number
- DEN210006
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- UK
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
PATIENT INFORMATION WAS NOT PROVIDED. LOT/SERIAL NUMBER WAS NOT PROVIDED, SO THE UDI AND EXPIRATION DATE COULD NOT BE DETERMINED. AS LOT NUMBER WAS NOT PROVIDED, MANUFACTURING DATE COULD NOT BE DETERMINED. ALUNG TECHNOLOGIES, INC. MANUFACTURES THE HEMOLUNG RAS AND CATHETER. THE INCIDENT OCCURRED IN TRURO, UNITED KINGDOM. THROUGH REVIEW OF THE FINAL CLINICAL STUDY ADVERSE EVENT LISTINGS, IT WAS REPORTED THAT A PATIENT EXPERIENCED THROMBOEMBOLISM, VENOUS EVENT OR VASCULAR OBSTRUCTION OF HEMOLUNG CATHETER. AS NO FURTHER NOTIFICATION WAS RECEIVED REGARDING THIS ADVERSE EVENT, NO FURTHER INFORMATION IS AVAILABLE. NO CAPA WAS OPENED BECAUSE OF THIS EVENT. THROMBOEMBOLISM, CATHETER CLOTTING IS A KNOWN POTENTIAL COMPLICATION THAT CAN OCCUR DURING EXTRACORPOREAL THERAPY. ALUNG TECHNOLOGIES, INC. WILL CONTINUE TO MONITOR ANY ISSUES AS THEY ARE REPORTED. THIS MDR IS BEING FILED IN RESPONSE TO A RETROSPECTIVE VIEW OF ALL ALUNG TECHNOLOGIES, INC. COMPLAINTS, WHICH IDENTIFIED THAT THE REPORTING DECISION FOR THIS COMPLAINT WAS NOT CORRECT. THIS MDR IS BEING FILED RETROSPECTIVELY TO CORRECT THE ERROR IN THE REPORTING DECISION.
ALUNG TECHNOLOGIES, INC. RECEIVED A REPORT OF A PATIENT EXPERIENCING A DISLOGED BLOOD CLOT, VENOUS EVENT, OR VASCULAR OBSTRUCTION OF THE HEMOLUNG CATHETER DURING HEMOLUNG THERAPY. THE EVENT RESULTED IN NON-ELECTIVE THERAPY CESSATION. NO FURTHER INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 750516 | HEMOLUNG RAS | CANNULA, CATHETER | DQR | ALUNG TECHNOLOGIES, INC |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Female | Other |